We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Control Program (PEINCA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00920504
First Posted: June 15, 2009
Last Update Posted: February 9, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Basel
University Hospital Freiburg
University of California, San Francisco
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland
  Purpose
The purpose of this pilot study is to refine and test an advanced and adapted German version of the PRO-SELF© Plus Pain Control Program (PCP), an educational intervention directed at cancer pain patients and their families to enhance their pain self management abilities, and to calculate effect sizes for the planning of a sufficiently powered randomized controlled trial (RCT).

Condition Intervention
Neoplasm Metastasis Behavioral: German PRO-SELF(c) Plus Pain Control Program (PCP) Other: Standard Care

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Control Program, an Educational Intervention Directed at Patients and Their Family Caregivers to Reduce Cancer Pain and Related Symptoms

Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • average and worst pain as reported daily by patients on a scale from 0 (no pain) to 10 (worst imaginable pain) [ Time Frame: measured daily for 10 weeks and in week 14 and 22 ]

Secondary Outcome Measures:
  • patients' knowledge of cancer pain management [ Time Frame: baseline, week 6, 10, 14 and 22 ]

Enrollment: 39
Study Start Date: June 2009
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: German PRO-SELF(c) Plus PCP
Group receives 10 weeks German PRO-SELF(c) Plus PCP intervention program
Behavioral: German PRO-SELF(c) Plus Pain Control Program (PCP)
Educational intervention directed at patients and their family caregivers to reduce cancer pain and related symptoms
Active Comparator: Standard Care
control group receives attention control and standard care
Behavioral: German PRO-SELF(c) Plus Pain Control Program (PCP)
Educational intervention directed at patients and their family caregivers to reduce cancer pain and related symptoms
Other: Standard Care
Patients in the standard care group will receive routine care provided by their treating physicians without any further care concerning the PRO-SELF© PCP. Patients in the standard care group will be seen by a research nurse in their homes at weeks 1, 2, 4, 6, 8 and 10 and telephone interviews will be conducted at weeks 3, 5, 7 and 9 but the focus of the visits and phone calls will be data collection only.

Detailed Description:

Background: Cancer patients experience multiple symptoms throughout the different stages of their illness, with pain as one of the most frequent. Even though effective treatment options exist, more than 40% of all cancer pain patients do not receive adequate pain management. For pain control, in addition to state of the art treatment by professionals, patients and their family caregivers (FCs) have to use self care strategies on a daily basis, a complex process that profits from targeted support by health care providers (HCPs). In phase 1 of this study, the intervention and the study instruments have been translated, adapted and advanced.

Aims: The purpose of this pilot study is to refine and test an advanced and adapted German version of the PRO-SELF© Plus Pain Control Program (PCP), an educational intervention directed at cancer pain patients and their families to enhance their pain self management abilities, and to calculate effect sizes for the planning of a sufficiently powered randomized controlled trial (RCT).

Methods: The advanced and adapted German version of the PRO-SELF© Plus PCP will be tested in a pilot RCT in cancer patients with pain from bone metastasis, compared with standard care, with effect sizes being calculated for the planning of a sufficiently powered RCT. A qualitative sub study will explore patients' and FCs' experiences with pain management, with the educational intervention, and their view of burden and benefit from study participation.

Intervention: The PRO-SELF© Plus PCP is based on three key strategies: (a) provision of information, (b) skill building, and (c) nurse coaching. The 10-week educational program comprises a structured part (teaching of pain management skills including the use of a weekly pillbox, the use of a pain management diary and written instructions on how to communicate with the physician about unrelieved pain) and a tailored part. The patient's answers on questions about his knowledge of pain management serve as basis for tailoring the teaching (academic detailing).

Data analysis: Main outcome variables will be average and worst pain as reported daily by the patient. In order to determine effect sizes for main effect of group, main effect of time and the group by time interaction a repeated measure longitudinal design will be used employing a linear mixed model approach. For the qualitative part, interviews will be analyzed using content analysis.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Outpatients
  • with cancer related pain ≥ 3 on a scale of 0-10 during the last two weeks,
  • estimated life expectancy of > 6 months as assessed by the physician,
  • 18 years of age or older,
  • able to understand, read and write German,
  • have access to a telephone,
  • live in a 1 hour distance around Freiburg or are willing to travel to Freiburg for each visit, agree to participate and give written in-formed consent

Exclusion Criteria:

  • documented previous or current psychiatric disorder or cognitive impairment as assessed by the physician (that is, unable to understand and provide informed consent),
  • visual or hearing impairment that prevents adequate communication,
  • a named FC who is not willing to participate in the study
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00920504


Locations
Germany
Tumorzentrum Ludwig Heilmeyer Comprehensive Cancer Center Freiburg
Freiburg, Germany, 79106
Sponsors and Collaborators
University Hospital, Basel, Switzerland
University of Basel
University Hospital Freiburg
University of California, San Francisco
Investigators
Principal Investigator: Elisabeth Spichiger, PhD Institute of Nursing Science, Faculty of Medicine, University of Basel, Switzerland
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT00920504     History of Changes
Other Study ID Numbers: PEINCA
First Submitted: June 12, 2009
First Posted: June 15, 2009
Last Update Posted: February 9, 2012
Last Verified: February 2012

Keywords provided by University Hospital, Basel, Switzerland:
Mesh: patient education as topic
Mesh: neoplasms
Mesh: medication therapy management
pain self management
symptom management
education of patients with pain from neoplasm metastases

Additional relevant MeSH terms:
Neoplasms
Neoplasm Metastasis
Neoplastic Processes
Pathologic Processes